Covered recipient · General Payments record
MALAK P ZACCA SHAMMAS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,639.89
- Reported across 131 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.86 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $230.29 | 12 |
| Amgen Inc. | $74.59 | 4 |
| Lilly USA, LLC | $69.00 | 3 |
| Janssen Pharmaceuticals, Inc | $44.02 | 1 |
| PFIZER INC. | $28.98 | 1 |
| Alnylam Pharmaceuticals Inc. | $22.04 | 1 |
| GlaxoSmithKline, LLC. | $20.20 | 1 |
| Merck Sharp & Dohme Corporation | $20.01 | 1 |
| Currax Pharmaceuticals LLC | $15.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.77 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386286 | CMS |
| ABBVIE INC. | $29.48 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386288 | CMS |
| ABBVIE INC. | $27.37 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386290 | CMS |
| ABBVIE INC. | $1.59 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386292 | CMS |
| ABBVIE INC. | $32.83 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386294 | CMS |
| ABBVIE INC. | $1.26 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386296 | CMS |
| ABBVIE INC. | $14.80 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386298 | CMS |
| ABBVIE INC. | $34.77 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386300 | CMS |
| ABBVIE INC. | $2.52 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386302 | CMS |
| ABBVIE INC. | $20.83 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386304 | CMS |
| ABBVIE INC. | $23.90 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386306 | CMS |
| ABBVIE INC. | $21.17 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106386308 | CMS |
| Alnylam Pharmaceuticals Inc. | $22.04 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125848966 | CMS |
| Amgen Inc. | $16.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421442 | CMS |
| Amgen Inc. | $18.45 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421444 | CMS |
| Amgen Inc. | $23.24 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421446 | CMS |
| Amgen Inc. | $16.55 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421448 | CMS |
| Currax Pharmaceuticals LLC | $15.73 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089513016 | CMS |
| GlaxoSmithKline, LLC. | $20.20 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116317582 | CMS |
| Janssen Pharmaceuticals, Inc | $44.02 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077919627 | CMS |
| Lilly USA, LLC | $24.10 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135146882 | CMS |
| Lilly USA, LLC | $22.68 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135154364 | CMS |
| Lilly USA, LLC | $22.22 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135162923 | CMS |
| Merck Sharp & Dohme LLC | $20.01 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141832733 | CMS |
| PFIZER INC. | $28.98 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131882936 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.